Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis (AD)”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02601703
What this trial is testing

To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

Who this might be right for
Atopic Dermatitis
Glenmark Pharmaceuticals Ltd. India 1,110
Not applicableLooking for participantsNCT07746427
What this trial is testing

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Weill Medical College of Cornell University 40
Testing effectiveness (Phase 2)Study completedNCT07103174
What this trial is testing

MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Shanghai Mabgeek Biotech.Co.Ltd 60
Large-scale testing (Phase 3)Study completedNCT05398445
What this trial is testing

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

Who this might be right for
Atopic Dermatitis
Amgen 769
Post-approval studies (Phase 4)Study completedNCT05507580
What this trial is testing

Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 461
Testing effectiveness (Phase 2)Study completedNCT06101823
What this trial is testing

Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)

Who this might be right for
Atopic Dermatitis
Insmed Incorporated 50
Not applicableNot Yet RecruitingNCT07550452
What this trial is testing

Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to Interleukin-4 Receptor Alpha(IL-4Rα) Inhibitors: A Prospective, Multicenter, Real-World Study

Who this might be right for
Atopic Dermatitis (AD)
Peking University People's Hospital 300
Large-scale testing (Phase 3)WithdrawnNCT04666675
What this trial is testing

Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Who this might be right for
Atopic Dermatitis (AD)
AbbVie
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06756126
What this trial is testing

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Akeso 24
Not applicableEnded earlyNCT05250115
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 112
Early research (Phase 1)Study completedNCT07336940
What this trial is testing

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Enveda Therapeutics 9
Early research (Phase 1)Looking for participantsNCT07693738
What this trial is testing

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
AD
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 96
Large-scale testing (Phase 3)Study completedNCT06224192
What this trial is testing

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 151
Post-approval studies (Phase 4)Study completedNCT04033367
What this trial is testing

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Who this might be right for
Atopic Dermatitis
Sanofi 188
Not applicableLooking for participantsNCT05391061
What this trial is testing

Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 1,100
Large-scale testing (Phase 3)Study completedNCT03345914
What this trial is testing

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 367
Not applicableLooking for participantsNCT07544862
What this trial is testing

Stapokibart Injection in Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis (AD)
Chengdu Kangnuoxing Biopharma,Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT05724199
What this trial is testing

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 746
Large-scale testing (Phase 3)Study completedNCT03346434
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 202
Testing effectiveness (Phase 2)Ended earlyNCT05984784
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic DermatitisAD
Inmagene LLC 13
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation